Powered by: Motilal Oswal
2026-11-14 11:38:31 am | Source: Prabhudas Lilladher Ltd
Buy Fortis Healthcare Ltd For Target Rs. 950 by Prabhudas Liladhar Capital Ltd
Buy Fortis Healthcare Ltd For Target Rs. 950 by Prabhudas Liladhar Capital Ltd

Margin caution for H2

Fortis Healthcare (FORH) reported EBITDA growth of 19% YoY adjusted for EOSP cost which was in-line with our estimate. Though hospital margin has improved by 530bps over FY23-FY26 to 22.2%, we see further scope for improvement aided by

1) improving case and payor mix

2) cost rationalization initiatives and ramp-up of Manesar and Greater Noida unit

3) new brownfield bed additions. Additionally, we expect margin to expand further, driven by the recent acquisition of People Tree Hospital, Shrimann Hospital and the O&M agreement with Gleneagles. Our FY28E and FY29E EBITDA ex ESOP broadly remain unchanged. We expect FORH to clock 19% EBITDA CAGR ex ESOP over FY26-28E. At CMP, the stock is trading at 19x EV/EBITDA on Sept 2028E, adjusted for Agilus stake and ESOP. Maintain ‘BUY’ rating with revised TP of INR 950/ share; valuing at 23x EV/EBITDA for hospital segment on Sept2028E.

Delivers 21% YoY EBITDA growth in Hospitals:

FORH’s consolidated EBITDA adjusted for ESOPs charges; increased 19% YoY to INR 6.6bn, vs our estimate of INR 6.5bn. Consol margins adjusted for ESOPs increased by ~35bps YoY and 190bps QoQ to 24.2%. Hospital business EBITDA adjusted for ESOPs reported at INR 5.5bn, up 21% YoY (PLe: INR 5.3bn). Overall hospital OPM increased by 40bps YoY and 175bps QoQ to 23.3%. Diagnostic business EBITDA increased 12% YoY to INR 1.2bn (in line with Ple), with OPM of 29.9% (up ~60bps YoY). Net debt decreased by INR 450mn QoQ to INR 21.9bn. FORH expanded its presence in Delhi; signed an O&M agreement for a 400-bed hospital and acquired Suguna Hospital, a 110-bed facility in Bengaluru, with expansion potential to ~150 beds.

Occupancy improved on seasonality & healthy 7% YoY ARPP growth:

FORH consolidated revenue increased by 17% YoY (8% QoQ) to INR 27.3bn; we estimated INR 26.8bn. Hospital business revenue increased 19% YoY to INR 23.4bn; we estimated INR 22.8bn. Diagnostic business net revenue grew 10% YoY to INR 3.9bn; in line with our estimates. Hospital occupancy increased by 300 bps QoQ and 100bps YoY to 72%. ARPP grew ~7% YoY to INR 210k during the quarter

 

Please refer disclaimer at Report
SEBI Registration number is INH000000933

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here